Physician

Anan H Said, MD

According to 2025 Medicare claims, Anan Said, MD (NPI: 1780983205) practices gastroenterology in the Altoona, PA market, with the plurality of this provider's patient population coming from Blair, PA. This provider's primary affiliated billing organization is REGIONAL GASTROENTEROLOGY ASSOCIATES OF LANCASTER, LTD. (NPI: 1154422806; TIN: 232812220) and primary practice location at 17601-2644. Said is affiliated with the Lancaster General Health Community Care Collaborative, LLC (ACO ID: A2019) and AdvantagePoint Health Alliance - Laurel Highlands, LLC (ACO ID: A4657), participating under the MSSP model.

Said's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 383 traditional Medicare patients, billed 7,927 HCPCS/CPT codes, and received $201,342 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 357 prescription claims across 216 beneficiaries totaling $73,813 in drug costs, led by Linzess (Linaclotide). Open Payments data shows 103 records totaling $14,789. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $43,371 to $201,342. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $890 and ending at $73,813. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	262	458	$43,371
2019	280	864	$64,962
2020	278	1,914	$83,645
2021	446	3,707	$192,484
2022	380	3,384	$139,548
2023	400	5,290	$158,852
2024	383	7,927	$201,342

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	15	36	$890
2017	13	30	$585
2018	96	177	$214,992
2019	78	107	$8,846
2020	200	346	$88,639
2021	281	453	$76,693
2022	284	475	$65,153
2023	282	422	$77,526
2024	216	357	$73,813

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	138	139	$212
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	43	43	$126
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	33	33	$66
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	128	139	$60
45380	Biopsy of large bowel using a flexible endoscope	101	101	$49

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Linzess	Linaclotide	22	1,260	$22,040
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	82	638	$5,300
Pantoprazole Sodium	Pantoprazole Sodium	116	9,635	$2,686
Cholestyramine	Cholestyramine (With Sugar)	15	435	$941
Famotidine	Famotidine	22	1,260	$519

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	103	$14,789	Phathom Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anan H. Said, MD?

Tedicare shows public-source Medicare data for Anan H. Said, MD (NPI 1780983205), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anan H. Said, MD have ACO affiliation data?

Anan H. Said, MD is shown with ACO affiliation data for Lancaster General Health Community Care Collaborative, LLC (MSSP, ACO ID A2019) and AdvantagePoint Health Alliance - Laurel Highlands, LLC (MSSP, ACO ID A4657).

What billing organization is linked to Anan H. Said, MD?

Anan H. Said, MD is linked to REGIONAL GASTROENTEROLOGY ASSOCIATES OF LANCASTER, LTD. (billing NPI 1154422806) in the available physician profile data.

Does Anan H. Said, MD have Open Payments data?

Anan H. Said, MD has 103 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.